LINC02272

Across TCGA pan-cancer cohorts, LINC02272 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated LINC02272 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher LINC02272 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02272 expression acts as an unfavorable survival marker, although some lineages such as UCS show a favorable association.

STAD, KICH, and LUAD are the cancer types where LINC02272 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	All	0.268	0.595	<.001	144	view →
KICH	DFS	Tertile	All	0.102	0.848	.004	39	view →
LUAD	OS	Tertile	III,IV	0.127	0.664	.001	36	view →
LIHC	OS	Tertile	All	0.226	0.773	.008	36	view →
LUSC	OS	Tertile	All	0.411	0.683	.002	36	view →
UCS	DFS	Quartile	III,IV	0.699	0.333	.014	18	view →
ACC	DFS	Tertile	All	0.068	0.623	.015	18	view →
UCEC	OS	Tertile	All	0.276	0.700	.004	18	view →
GBM	DFS	Tertile	All	0.145	0.306	.030	9	view →
KIRC	OS	Tertile	All	0.776	0.883	.020	6	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

LINC02272–STAD (OS)

Open the STAD breakdown →